Precigen (NasdaqGS:PGEN) Q4 2025 Earnings call March 25, 2026 04:30 PM ET Company ParticipantsHarry Thomasian Jr. - CFOHelen Sabzevari - President and CEOJason Butler - Managing Director of Biotechnology Equity ResearhMichael DiFiore - Managing DirectorPhil Tennant - Chief Commercial OfficerRútul R. Shah - COOSteven Harasym - VP of Investor RelationsConference Call ParticipantsBrian Chung - Investment Risk AnalystSwayampakula Ramakanth - Managing Director and Senior Equity AnalystOperatorThis call is being ...